ArticleTherapeutic advances in medical oncology2026

Bevacizumab plus iparomlimab/tuvonralimab with hepatic artery infusion chemotherapy followed by stereotactic body radiotherapy in patients with BCLC stage C hepatocellular carcinoma with thrombus and/or extrahepatic oligometastases (BITS-TO-HCC): study protocol of a prospective, single-center, single-arm, phase II study.

Yuxin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.